Qiagen NV | QIA - Gross Profit On Sales

Stock Price
43.17
Daily Change
-0.31 -0.70%
Monthly
1.90%
Yearly
8.86%
Q1 Forecast
43.53

Qiagen NV reported $344.8M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
argenx SE USD 1.02B 180.32M Sep/2025
Avita Medical AUD 14.95M 1.18M Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Moderna USD 809M 791M Sep/2025
Organon & Co USD 857M 17M Sep/2025
Qiagen NV USD 344.8M 10.51M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.37B 38.6M Sep/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025